These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9316553)

  • 1. Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension.
    Palatini P; Penzo M; Canali C; Dorigatti F; Pessina AC
    Am J Med; 1997 Sep; 103(3):208-16. PubMed ID: 9316553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'White coat' hypertension. No harm for the heart.
    Gosse P; Promax H; Durandet P; Clementy J
    Hypertension; 1993 Nov; 22(5):766-70. PubMed ID: 8225536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "White coat" hypertension and alerting reaction in elderly and very elderly hypertensive patients.
    Trenkwalder P; Plaschke M; Steffes-Tremer I; Lydtin H
    Blood Press; 1993 Dec; 2(4):262-71. PubMed ID: 8173694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study.
    Palatini P; Mormino P; Santonastaso M; Mos L; Dal Follo M; Zanata G; Pessina AC
    Hypertension; 1998 Jan; 31(1):57-63. PubMed ID: 9449391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task Force II: blood pressure measurement and cardiovascular outcome.
    Staessen JA; Asmar R; De Buyzere M; Imai Y; Parati G; Shimada K; Stergiou G; Redón J; Verdecchia P;
    Blood Press Monit; 2001 Dec; 6(6):355-70. PubMed ID: 12055415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
    Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.
    Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB
    Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No impact of blood pressure variability on microalbuminuria and left ventricular geometry: analysis of daytime variation, diurnal variation and 'white coat' effect.
    Kristensen KS; Høegholm A; Bang LE; Gustavsen PH; Poulsen CB
    Blood Press Monit; 2001 Jun; 6(3):125-31. PubMed ID: 11518834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between blood pressure determination anxiety and hypertensive complications].
    Penzo M; Guzzardi G; Palatini P
    Cardiologia; 1995 Feb; 40(2):117-22. PubMed ID: 7671275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability.
    Palatini P; Penzo M; Racioppa A; Zugno E; Guzzardi G; Anaclerio M; Pessina AC
    Arch Intern Med; 1992 Sep; 152(9):1855-60. PubMed ID: 1387782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study.
    Manning G; Rushton L; Millar-Craig MW
    J Hum Hypertens; 1999 Dec; 13(12):817-22. PubMed ID: 10618670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension.
    Cardillo C; De Felice F; Campia U; Folli G
    Hypertension; 1993 Jun; 21(6 Pt 1):836-44. PubMed ID: 8500864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White-coat effect in normotension and hypertension.
    Zakopoulos NA; Kotsis VT; Pitiriga VCh; Toumanidis ST; Lekakis JP; Nanas SN; Vemmos KN; Stamatelopoulos SF; Moulopoulos SD
    Blood Press Monit; 2002 Oct; 7(5):271-6. PubMed ID: 12409886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Masked hypertension and target organ damage in treated hypertensive patients.
    Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
    Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of mild hypertension by ambulatory blood pressure monitoring.
    Weber MA; Neutel JM; Smith DH; Graettinger WF
    Circulation; 1994 Nov; 90(5):2291-8. PubMed ID: 7955186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White-coat hypertension and cardiac organ damage in elderly subjects.
    Rizzo V; Cicconetti P; Bianchi A; Lorido A; Morelli S; Vetta F; Salza MC; Marigliano V
    J Hum Hypertens; 1996 May; 10(5):293-8. PubMed ID: 8817402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.